NPRC/Institute
Washington NPRC
Summary of Study
The study showed that two-component self-assembling SARS-CoV-2 RBC nanoparticle vaccine candidates elicit potent neutralizing Ab responses targeting multiple distinct RBT epitopes.
Year Published
2020
References
PMID: 33160446/doi: 10.1016/j.cell.2020.10.043
Contact Info
David Veesler: dveesler@uw.edu
Keywords
SARS-CoV-2, two-component nanoparticle vaccine, mice and primates
Coronavirus Investigated*
NHP Species
date entered
Study Type